Skip to main content
Top
Published in: Endocrine 2/2022

23-05-2022 | Lymphoma | Original Article

Clinical analysis of the etiological spectrum of bilateral adrenal lesions: A large retrospective, single-center study

Authors: Fangfang Yan, Jinyang Zeng, Yulong Chen, Yu Cheng, Yu Pei, Li Zang, Kang Chen, Weijun Gu, Jin Du, Qinghua Guo, Xianling Wang, Jianming Ba, Zhaohui Lyu, Jingtao Dou, Guoqing Yang, Yiming Mu

Published in: Endocrine | Issue 2/2022

Login to get access

Abstract

Purpose

To investigate the clinical characteristics, endocrinological function, and etiology of bilateral adrenal lesions in hospitalized patients.

Methods

A retrospective study of 777 patients with bilateral adrenal lesions was conducted at the Chinese People’s Liberation Army General Hospital between January 2013 and January 2018. Patients’ demographic features, hormonal profiles, imaging findings, and histopathological findings were reviewed from database records.

Results

Of the 777 patients with bilateral adrenal lesions, 495 were men. The mean age at diagnosis was 52.0 ± 13.0 years. Overall, 511 (65.8%) cases were benign, followed by adrenal metastases (n = 224, 28.8%), pheochromocytoma (n = 26, 3.3%), adrenal lymphoma (n = 9, 1.2%), and adrenal corticocarcinoma (ACC; n = 7, 0.9%). Hormonal evaluation revealed that 34.3% of bilateral adrenal lesions were functional. The primary etiologies of functional lesions were primary aldosteronism (16.6%, 129/777), and primary bilateral macronodular adrenocortical hyperplasia (PBMAH; 8.8%, 68/777). Patients with lymphoma and metastases were significantly older than those with benign nonfunctional lesions (60.4 ± 11.0 years vs. 54.5 ± 10.4 years and 57.9 ± 10.8 years vs. 54.5 ± 10.4 years, respectively; both P < 0.001). Lesions in patients with adrenal lymphoma, ACC, pheochromocytoma, metastases, congenital adrenal hyperplasia, tuberculosis, and Cushing’s syndrome were significantly larger than benign nonfunctional lesions (all P < 0.001).

Conclusion

Benign adrenal lesions and metastases from the lungs are the most common causes of bilateral adrenal lesions. Primary aldosteronism and PBMAH are the most prevalent functional lesions. Moreover, patients with lymphoma or metastases are older and their masses are larger.
Literature
4.
go back to reference L.L. Li, G. Yang, L. Zhao, J.T. Dou, W.J. Gu, Z.H. Lv, J.M. Lu, Y.M. Mu, Baseline Demographic and Clinical Characteristics of Patients with Adrenal Incidentaloma from a Single Center in China: A Survey. Int J Endocrinol. 3093290 (2017). https://doi.org/10.1155/2017/3093290 L.L. Li, G. Yang, L. Zhao, J.T. Dou, W.J. Gu, Z.H. Lv, J.M. Lu, Y.M. Mu, Baseline Demographic and Clinical Characteristics of Patients with Adrenal Incidentaloma from a Single Center in China: A Survey. Int J Endocrinol. 3093290 (2017). https://​doi.​org/​10.​1155/​2017/​3093290
6.
go back to reference J. Maskur, M. Gruber, M. Peitzsch, D. Kaden, G. Di Dalmazi, M. Bidlingmaier, S. Zopp, K. Langton, J. Fazel, F. Beuschlein, S.R. Bornstein, M. Reincke, G. Eisenhofer, Plasma steroid profiles in subclinical compared with overt adrenal cushing syndrome. J. Clin. Endocrinol. Metab. 104(10), 4331–4340 (2019). https://doi.org/10.1210/jc.2018-02348CrossRef J. Maskur, M. Gruber, M. Peitzsch, D. Kaden, G. Di Dalmazi, M. Bidlingmaier, S. Zopp, K. Langton, J. Fazel, F. Beuschlein, S.R. Bornstein, M. Reincke, G. Eisenhofer, Plasma steroid profiles in subclinical compared with overt adrenal cushing syndrome. J. Clin. Endocrinol. Metab. 104(10), 4331–4340 (2019). https://​doi.​org/​10.​1210/​jc.​2018-02348CrossRef
8.
go back to reference R. Garcia-Carbonero, F. Matute Teresa, E. Mercader-Cidoncha, M. Mitjavila-Casanovas, M. Robledo, I. Tena, C. Alvarez-Escola, M. Arístegui, M.R. Bella-Cueto, C. Ferrer-Albiach, F.A. Hanzu, Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas. Clin. Transl. Oncol. 23(10), 1995–2019 (2021). https://doi.org/10.1007/s12094-021-02622-9CrossRefPubMedPubMedCentral R. Garcia-Carbonero, F. Matute Teresa, E. Mercader-Cidoncha, M. Mitjavila-Casanovas, M. Robledo, I. Tena, C. Alvarez-Escola, M. Arístegui, M.R. Bella-Cueto, C. Ferrer-Albiach, F.A. Hanzu, Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas. Clin. Transl. Oncol. 23(10), 1995–2019 (2021). https://​doi.​org/​10.​1007/​s12094-021-02622-9CrossRefPubMedPubMedCentral
9.
go back to reference J.W. Funder, R.M. Carey, F. Mantero, M.H. Murad, M. Reincke, H. Shibata, M. Stowasser, W.F. Young, The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101(5), 1889–1916 (2016). https://doi.org/10.1210/jc.2015-4061CrossRefPubMed J.W. Funder, R.M. Carey, F. Mantero, M.H. Murad, M. Reincke, H. Shibata, M. Stowasser, W.F. Young, The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101(5), 1889–1916 (2016). https://​doi.​org/​10.​1210/​jc.​2015-4061CrossRefPubMed
11.
go back to reference H.L. Claahsen-van der Grinten, P.W. Speiser, S.F. Ahmed, W. Arlt, R.J. Auchus, H. Falhammar, C.E. Flück, L. Guasti, A. Huebner, B.B.M. Kortmann, N. Krone, D.P. Merke, M.L. Miller, A. Nordenström, N. Reisch, D.E. Sandberg, N.M.M.L. Stikkelbroeck, P. Touraine, A. Utari, S.A. Wudy, P.C. White, Congenital adrenal hyperplasia-current insights in pathophysiology, diagnostics, and management. Endocr. Rev. 43(1), 91–159 (2022). https://doi.org/10.1210/endrev/bnab016CrossRefPubMed H.L. Claahsen-van der Grinten, P.W. Speiser, S.F. Ahmed, W. Arlt, R.J. Auchus, H. Falhammar, C.E. Flück, L. Guasti, A. Huebner, B.B.M. Kortmann, N. Krone, D.P. Merke, M.L. Miller, A. Nordenström, N. Reisch, D.E. Sandberg, N.M.M.L. Stikkelbroeck, P. Touraine, A. Utari, S.A. Wudy, P.C. White, Congenital adrenal hyperplasia-current insights in pathophysiology, diagnostics, and management. Endocr. Rev. 43(1), 91–159 (2022). https://​doi.​org/​10.​1210/​endrev/​bnab016CrossRefPubMed
13.
go back to reference M. Fassnacht, O.M. Dekkers, T. Else, E. Baudin, A. Berruti, R. de Krijger, H.R. Haak, R. Mihai, G. Assie, M. Terzolo, European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 179(4), G1–G46 (2018). https://doi.org/10.1530/EJE-18-0608CrossRefPubMed M. Fassnacht, O.M. Dekkers, T. Else, E. Baudin, A. Berruti, R. de Krijger, H.R. Haak, R. Mihai, G. Assie, M. Terzolo, European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 179(4), G1–G46 (2018). https://​doi.​org/​10.​1530/​EJE-18-0608CrossRefPubMed
15.
17.
26.
go back to reference G.A. Alencar, A.M. Lerario, M.Y. Nishi, B.M. Mariani, M.Q. Almeida, J. Tremblay, P. Hamet, I. Bourdeau, M.C.N. Zerbini, M.A.A. Pereira, G.C. Gomes, M. Souza Rocha, J.L. Chambo, A. Lacroix, B.B. Mendonca, M.C.B.V. Fragoso, ARMC5 mutations are a frequent cause of primary macronodular adrenal Hyperplasia. J. Clin. Endocrinol. Metab. 99(8), E1501–9 (2014). https://doi.org/10.1210/jc.2013-4237CrossRefPubMed G.A. Alencar, A.M. Lerario, M.Y. Nishi, B.M. Mariani, M.Q. Almeida, J. Tremblay, P. Hamet, I. Bourdeau, M.C.N. Zerbini, M.A.A. Pereira, G.C. Gomes, M. Souza Rocha, J.L. Chambo, A. Lacroix, B.B. Mendonca, M.C.B.V. Fragoso, ARMC5 mutations are a frequent cause of primary macronodular adrenal Hyperplasia. J. Clin. Endocrinol. Metab. 99(8), E1501–9 (2014). https://​doi.​org/​10.​1210/​jc.​2013-4237CrossRefPubMed
27.
go back to reference F.R. Faucz, M. Zilbermint, M.B. Lodish, E. Szarek, G. Trivellin, N. Sinaii, A. Berthon, R. Libé, G. Assié, S. Espiard, L. Drougat, B. Ragazzon, J. Bertherat, C.A. Stratakis, Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation. J. Clin. Endocrinol. Metab. 99(6), E1113–1119 (2014). https://doi.org/10.1210/jc.2013-4280CrossRefPubMedPubMedCentral F.R. Faucz, M. Zilbermint, M.B. Lodish, E. Szarek, G. Trivellin, N. Sinaii, A. Berthon, R. Libé, G. Assié, S. Espiard, L. Drougat, B. Ragazzon, J. Bertherat, C.A. Stratakis, Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation. J. Clin. Endocrinol. Metab. 99(6), E1113–1119 (2014). https://​doi.​org/​10.​1210/​jc.​2013-4280CrossRefPubMedPubMedCentral
28.
go back to reference G. Assié, R. Libé, S. Espiard, M. Rizk-Rabin, A. Guimier, W. Luscap, O. Barreau, L. Lefèvre, M. Sibony, L. Guignat, S. Rodriguez, K. Perlemoine, F. René-Corail, F. Letourneur, B. Trabulsi, A. Poussier, N. Chabbert-Buffet, F. Borson-Chazot, L. Groussin, X. Bertagna, C.A. Stratakis, B. Ragazzon, J. Bertherat, ARMC5 mutations in macronodular adrenal hyperplasia with Cushing’s syndrome. N. Engl. J. Med 369(22), 2105–2114 (2013). https://doi.org/10.1056/NEJMoa1304603CrossRefPubMedPubMedCentral G. Assié, R. Libé, S. Espiard, M. Rizk-Rabin, A. Guimier, W. Luscap, O. Barreau, L. Lefèvre, M. Sibony, L. Guignat, S. Rodriguez, K. Perlemoine, F. René-Corail, F. Letourneur, B. Trabulsi, A. Poussier, N. Chabbert-Buffet, F. Borson-Chazot, L. Groussin, X. Bertagna, C.A. Stratakis, B. Ragazzon, J. Bertherat, ARMC5 mutations in macronodular adrenal hyperplasia with Cushing’s syndrome. N. Engl. J. Med 369(22), 2105–2114 (2013). https://​doi.​org/​10.​1056/​NEJMoa1304603CrossRefPubMedPubMedCentral
32.
go back to reference G. Goh, U.I. Scholl, J.M. Healy, M. Choi, M.L. Prasad, C. Nelson-Williams, J.W. Kunstman, R. Korah, A. Suttorp, D. Dietrich, M. Haase, H.S. Willenberg, P. Stålberg, P. Hellman, G. Akerström, P. Björklund, T. Carling, R.P. Lifton, Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors. Nat. Genet 46(6), 613–617 (2014). https://doi.org/10.1038/ng.2956CrossRefPubMedPubMedCentral G. Goh, U.I. Scholl, J.M. Healy, M. Choi, M.L. Prasad, C. Nelson-Williams, J.W. Kunstman, R. Korah, A. Suttorp, D. Dietrich, M. Haase, H.S. Willenberg, P. Stålberg, P. Hellman, G. Akerström, P. Björklund, T. Carling, R.P. Lifton, Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors. Nat. Genet 46(6), 613–617 (2014). https://​doi.​org/​10.​1038/​ng.​2956CrossRefPubMedPubMedCentral
33.
go back to reference G. Raverot, F. Brucker-Davis, F. Archambeaud-Mouveroux, H. Lefebvre, M.-L. Nunes, A. Tabarin, A. Lienhardt, O. Chabre, M. Houang, M. Bottineau, S. Stror, L. Groussin, L. Guignat, L. Cabanes, A. Feydy, F. Bonnet, M.O. North, N. Dupin, S. Grabar, D. Duboc, J. Bertherat, Frequency and Incidence of Carney Complex Manifestations: A Prospective Multicenter Study With a Three-Year Follow-Up. J. Clin. Endocrinol. Metab. 105(3), dgaa002 (2020). https://doi.org/10.1210/clinem/dgaa002CrossRefPubMed G. Raverot, F. Brucker-Davis, F. Archambeaud-Mouveroux, H. Lefebvre, M.-L. Nunes, A. Tabarin, A. Lienhardt, O. Chabre, M. Houang, M. Bottineau, S. Stror, L. Groussin, L. Guignat, L. Cabanes, A. Feydy, F. Bonnet, M.O. North, N. Dupin, S. Grabar, D. Duboc, J. Bertherat, Frequency and Incidence of Carney Complex Manifestations: A Prospective Multicenter Study With a Three-Year Follow-Up. J. Clin. Endocrinol. Metab. 105(3), dgaa002 (2020). https://​doi.​org/​10.​1210/​clinem/​dgaa002CrossRefPubMed
Metadata
Title
Clinical analysis of the etiological spectrum of bilateral adrenal lesions: A large retrospective, single-center study
Authors
Fangfang Yan
Jinyang Zeng
Yulong Chen
Yu Cheng
Yu Pei
Li Zang
Kang Chen
Weijun Gu
Jin Du
Qinghua Guo
Xianling Wang
Jianming Ba
Zhaohui Lyu
Jingtao Dou
Guoqing Yang
Yiming Mu
Publication date
23-05-2022

Other articles of this Issue 2/2022

Endocrine 2/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.